Affiliation:
1. Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation
Abstract
This review (I part) presents an analysis of publications devoted to the ant-viral antiinfluenza activity of medicinal plants. It has shown that 63 species are found to be promising sources for obtaining anti-influenza drugs. Their roots, stems, leaves and fruits contain different chemical compounds inhibiting reproduction of influenza virus, both in vitro and in vivo. These compounds have different mechanisms of action. Some of them act upon components of the viral particle, others upon signaling pathways in the host cells. The first part of our review focuses on 28 species.
Publisher
The Russian Academy of Sciences
Reference70 articles.
1. Gasparini R., Amicizia D., Lai P.L., Bragazzi N.L., Panatto D. 2014. Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugs. – J. Prev. Med. Hyg. 55(3): 69–85. https://doi.org/10.15167/2421-4248/jpmh2014.55.3.432
2. Gubareva L.V., Kaiser L., Hayden F.G. 2000. Influenza virus neuraminidase inhibitors. – Lancet. 355(9206): 827–835. https://doi.org/10.1016/S0140-6736(99)11433-8
3. Yang T. 2019. Baloxavir Marboxil: The first cap-dependent endonuclease inhibitor for the treatment of influenza. – Ann. Pharmacother. 53(7): 754–759. https://doi.org/10.1177/1060028019826565
4. Uehara T., Hayden F.G., Kawaguchi K., Omoto S., Hurt A.C., De Jong M.D., Hirotsu N., Sugaya N., Lee N., Baba K., Shishido T., Tsuchiya K., Portsmouth S., Kida H. 2020. Treatment-emergent influenza variant viruses with reduced baloxavir susceptibility: impact on clinical and virologic outcomes in uncomplicated influenza. – J. Infect. Dis. 221(3): 346–355. https://doi.org/10.1093/infdis/jiz244
5. Chen Q., Lan H.Y., Peng W., Rahman K., Liu Q.C., Luan X., Zhang H. 2021. Isatis indigotica: a review of phytochemistry, pharmacological activities and clinical applications. – J. Pharm. Pharmacol. 73(9): 1137–1150. https://doi.org/10.1093/jpp/rgab014